SM04554, a Wnt activator from Samumed, is currently the only new drug worldwide at a phase 3 trial for androgenic alopecia
| M. Wt | 296.32 |
| Formula | C18H16O4 |
| Storage | Store at RT |
| Purity | ≥99% (HPLC) |
| CAS Number | 1360540-81-3 |
| Chemical name | 1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-4-phenylbutane-1,4-dione |
| Boiling Point | 500.1±50.0 °C(Predicted) |
| Appearance | Solid |
SM04554 not approved By FDA yet, not for human use,for research purpose only
Related Programs
| Seripiprant |
| Fevipiprant |
| CB-03-01 |
| WAY 316606 |
| RU58841 |
| way200070 |
| SM04554 |
Oteseconazole is an azole metalloenzyme inhibitor that targets CYP51 (also known as 14α demethylase) Technical Data for Oteseconazole M. Wt 527.4 Formula C23H16F7N5O2 Storage Store
Odevixibat is a medication for the treatment of progressive familial intrahepatic cholestasis (PFIC). Technical Data for Odevixibat M. Wt 740.93 Formula C37H48N4O8S2 Storage Store at
GSK2879552 free base CAS 1401966-69 GSK2879552 is an orally available, irreversible inhibitor of lysine specific demethylase 1 (LSD1; officially known as lysine demethylase 1A, KDM1A). It
Pyrilutamide KX-826 for the potential treatment of androgenetic alopecia in males and females KX-826 is a nonsteroidal antiandrogen (NSAA) – specifically, a selective high-affinity silent antagonist of the androgen receptor (AR) – which